Desar IME - Search Results

1

Fear, anxiety and depression in gastrointestinal stromal tumor (GIST) patients in the Netherlands: Data from a cross-sectional multicenter study.

van de Wal D, den Hollander D, Desar IME, Gelderblom H, Oosten AW, Reyners AKL, Steeghs N, Husson O, van der Graaf WTA. van de Wal D, et al. Among authors: desar ime. Int J Clin Health Psychol. 2024 Jan-Mar;24(1):100434. doi: 10.1016/j.ijchp.2023.100434. Epub 2024 Jan 9. Int J Clin Health Psychol. 2024. PMID: 38226006 Free PMC article.

2

Rapid and reliable identification of Streptococcus anginosus group isolates to the species level by real-time PCR and melting curve analysis.

Desar IM, de Boer M, Bens CC, Jacobs JA, Mouton JW, Dofferhoff AS, Klaassen CH. Desar IM, et al. J Microbiol Methods. 2008 Oct;75(2):372-4. doi: 10.1016/j.mimet.2008.06.022. Epub 2008 Jul 3. J Microbiol Methods. 2008. PMID: 18652853

3

The first-in-human study of the hydrogen sulfate (Hyd-sulfate) capsule of the MEK1/2 inhibitor AZD6244 (ARRY-142886): a phase I open-label multicenter trial in patients with advanced cancer.

Banerji U, Camidge DR, Verheul HM, Agarwal R, Sarker D, Kaye SB, Desar IM, Timmer-Bonte JN, Eckhardt SG, Lewis KD, Brown KH, Cantarini MV, Morris C, George SM, Smith PD, van Herpen CM. Banerji U, et al. Clin Cancer Res. 2010 Mar 1;16(5):1613-23. doi: 10.1158/1078-0432.CCR-09-2483. Epub 2010 Feb 23. Clin Cancer Res. 2010. PMID: 20179232 Free article. Clinical Trial.

4

Beyond RECIST: molecular and functional imaging techniques for evaluation of response to targeted therapy.

Desar IM, van Herpen CM, van Laarhoven HW, Barentsz JO, Oyen WJ, van der Graaf WT. Desar IM, et al. Cancer Treat Rev. 2009 Jun;35(4):309-21. doi: 10.1016/j.ctrv.2008.12.001. Epub 2009 Jan 10. Cancer Treat Rev. 2009. PMID: 19136215 Review.

5

The reverse side of the victory: flare up of symptoms after discontinuation of sunitinib or sorafenib in renal cell cancer patients. A report of three cases.

Desar IM, Mulder SF, Stillebroer AB, van Spronsen DJ, van der Graaf WT, Mulders PF, van Herpen CM. Desar IM, et al. Acta Oncol. 2009;48(6):927-31. doi: 10.1080/02841860902974167. Acta Oncol. 2009. PMID: 19452305 No abstract available.

6

Case studies showing clinical signs and management of cutaneous toxicity of the MEK1/2 inhibitor AZD6244 (ARRY-142886) in patients with solid tumours.

Desar IM, Bovenschen HJ, Timmer-Bonte AJ, Cantarini MV, Van Der Graaf WT, Van Rossum MM, Van Herpen CM. Desar IM, et al. Acta Oncol. 2010;49(1):110-3. doi: 10.3109/02841860903104152. Acta Oncol. 2010. PMID: 19634052 No abstract available.

7

Sorafenib reduces the percentage of tumour infiltrating regulatory T cells in renal cell carcinoma patients.

Desar IM, Jacobs JH, Hulsbergen-vandeKaa CA, Oyen WJ, Mulders PF, van der Graaf WT, Adema GJ, van Herpen CM, de Vries IJ. Desar IM, et al. Int J Cancer. 2011 Jul 15;129(2):507-12. doi: 10.1002/ijc.25674. Epub 2010 Nov 12. Int J Cancer. 2011. PMID: 20839259 Free article.

8

111In-bevacizumab imaging of renal cell cancer and evaluation of neoadjuvant treatment with the vascular endothelial growth factor receptor inhibitor sorafenib.

Desar IM, Stillebroer AB, Oosterwijk E, Leenders WP, van Herpen CM, van der Graaf WT, Boerman OC, Mulders PF, Oyen WJ. Desar IM, et al. J Nucl Med. 2010 Nov;51(11):1707-15. doi: 10.2967/jnumed.110.078030. Epub 2010 Oct 18. J Nucl Med. 2010. PMID: 20956472 Free article.

9

A phase I dose-escalation study to evaluate safety and tolerability of sorafenib combined with sirolimus in patients with advanced solid cancer.

Desar IM, Timmer-Bonte JN, Burger DM, van der Graaf WT, van Herpen CM. Desar IM, et al. Br J Cancer. 2010 Nov 23;103(11):1637-43. doi: 10.1038/sj.bjc.6605777. Epub 2010 Nov 2. Br J Cancer. 2010. PMID: 21045832 Free PMC article. Clinical Trial.

10

A new, simple and objective prognostic score for phase I cancer patients.

Füssenich LM, Desar IM, Peters ME, Teerenstra S, van der Graaf WT, Timmer-Bonte JN, van Herpen CM. Füssenich LM, et al. Eur J Cancer. 2011 May;47(8):1152-60. doi: 10.1016/j.ejca.2010.12.028. Epub 2011 Feb 25. Eur J Cancer. 2011. PMID: 21354785

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

143 results

Search Page